Essay On MRSA

Methicillin-resistant Staphylococcus aureus, or more commonly, MRSA, is an emerging infectious disease affecting many people worldwide. MRSA, in particular, is a very interesting disease because although many people can be carriers of it, it generally only affects those with a depressed immune system; this is why it is so prevalent in places like nursing homes and hospitals. It can be spread though surgeries, artificial joints, tubing, and skin-to-skin contact. Although there is not one specific treatment of this disease, there are ways to test what antibiotics work best and sometimes antibiotics aren’t even necessary.

Methicillin Staphylococcus aureus is defined as strains of bacteria that are resistant to beta-lactam agents, including the synthetic penicillins (eg, methicillin, oxacillin) and the cephalosporins. MRSA can resist the effects of many common antibiotics, so it is difficult to treat. If the infection spreads to the blood stream and becomes systemic may increases risk for life threatening complications. First sign of MRSA are small red bumps that resemble pimples, boils or spider bites. Next they may mature into deep and painful abscesses that require surgical draining. If the bacteria is not confined to the skin and infect the blood stream, causing potentially fatal infections in bones, joints, surgical wounds, the bloodstream, heart valves and lungs.

Currently it is resistant to, or rather unaffected by, commonly used antibiotics such as methicillin, amoxicillin, penicillin, oxacillin, and many others, and is consequently much more challenging to treat than most strains of staphylococcus aureus—or staph. Some antibiotics still work, but MRSA is constantly adapting, and researchers and developers are having a difficult time keeping up.

Methicillin-resistant Staphylococcus aureus, or MRSA, is a bacterium that is resistant to many available high- level beta-lactam antibiotics, which include penicillins, “antistaphylococcal” penicillins and cephalosporins. Staphyloccoci are the most important bacteria that cause disease in humans. MRSA is sometimes branded as a nosocomial infection as it usually plagues patients that are receiving treatment in a hospital. The skin is the most common site of infection, where MRSA can cause cellulitis, folliculitis, or boils in the skin, but can also commonly be found in the nose, underarm, groin, upper respiratory tract, intestine, vagina and rectal areas of the body. MRSA infections occur with there is a break in the skin that allows the Methicillin resistant

In conclusion, the importance of control and prevention in the spread of MRSA cannot be emphasised enough. MRSA clearly

MRSA (Methicillin Resistant Staphylococcus Aureus) is one of the most recent superbugs to become a health problem. MRSA is a species of Staphylococcus Aureus that is resistant to the antibiotic methicillin and antibiotics like it. Doctors are struggling to find proper treatment because of its resistance to the beta-lactam ring, the core of most antibiotics. The most lethal strain is the CC398 strain, most commonly found on livestock. There are approximately 80,000 invasive MRSA infections and 11,000 deaths every year. (CNN.com)

Methicillin-resistant Staphylococcus aureus (MRSA) is a drug resistant pathogen abundant in healthcare settings and the second most common overall cause of healthcare associated infections (HAIs) reported to the National Healthcare Safety Network (NHSN) (Jernigan & Kallan, 2010). The prevalence of MRSA is a significant problem found amongst many Intensive Care Units (ICUs) in the United States (US); critically ill patients are at higher risk for hospital-acquired infections. Acquisition and infection of MRSA may significantly prolong duration of hospital stays, increase healthcare costs, and contribute to higher mortality rates. According to national data, MRSA accounts for nearly 70 percent of Staphylococcus aureus strains isolated from

Hospital settings have harbored a disease-causing organism called Methicillin-resistant Staphylococcus aureus (MRSA) since the 1960s. However, hospitals aren’t the only settings at risk of a MRSA outbreak. In recent years’ healthy communities have seen a genetically distinct strain of MRSA, called community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA). Although this organism has been less resistant to antibiotics, it is more virulent and capable of causing illnesses (Alex & Letizia, 2007). The community should be aware of the risk factors for this infection and understand its signs, symptoms, and management.

When penicillin was released to the public in 1944, it was a miracle drug. Infections that had been killers were suddenly treatable. Doctors recommended it generously, both for illnesses that needed it and illnesses that didn’t. Before long, however, it took much stronger doses to see penicillin’s effects. When the antibiotic arms race began in 1944, most physicians assumed that new antibiotics would be discovered or created to keep up with the evolving resistance in bacteria, but the bacteria are constantly evolving new defenses and doctors are starting to run low on antibiotic ammunition. MRSA, methicillin-resistant Staphylococcus aureus, is one of many types of bacteria

MRSA stands for Methicillin-safe Staphylococcus aureus. MRSA is a bacteria that is very hard to treat that infections in animals’ and humans body. MRSA was initially reported in 1961 when a researcher found it and the first case was in 1968. It's impervious to a gathering of anti-infection agents which incorporate methicillin and this is the explanation why it's hard to treat. "Staphylococcus" is comprised of two Greek components. The main component, which is "staphule," implies a pack of grapes and the second component "kokkos" means berry. The two Greek components consolidate to frame the current Latin word "staphylococcus." "Aureus" is characterized as golden. Staphylococcus aureus is a circular bacterium yet that is not by any means

MRSA stands for methicillin-resistant Staphylococcus aureus and was founded in the 1960’s. It was not recognized until the 1990’s when there was a breakout in the hospitals. Healthcare professionals became frightened of this “Super-Bug” mainly because of the spread from one person to another. It became uncontrollable and staff were not aware of how to prevent the spread and treat the patients. It was then that the hospitals and nursing homes developed infection control measures in order to control and prevent further spread of MRSA.

Methicillin-resistant Staphylococcus aureus, also known as MRSA, is a “bacteria that are resistant to many antibiotics. Staph and MRSA can

Methicillin resistant Staphylococcus aureus (MRSA) has been a type of multidrug resistant organism and staph bacteria known to cause serious infection that can lead to long hospitalizations and death. It can begin as a simple infection on skin or in the lungs, and if left untreated, can lead to traveling to the bloodstream and causing sepsis (“Methicillin-resistant Staphylococcus aureus (MRSA), 2015”). The Centers for Disease Control and Prevention reports that 33 percent of individuals carry the staph bacteria intranasally and two percent of individuals carry MRSA (“Methicillin-resistant Staphylococcus aureus (MRSA), 2015”). Even though this is a serious issue among healthcare settings all over the country, the number of people affected

Methicillin-resistant Staphylococcus aureus (MRSA) bacteria are resistant to all beta-lactam antibiotics such as methicillin, penicillin, oxacillin, and amoxicillin. Sometimes called a “super-bug” because of its ability to resist so many of our antibiotics. MRSA can be fatal and according to the CDC, of the over 80,000 invasive MRSA infections every year, 11,285 related deaths occur. Methicillin-resistant Staphylococcus aureus (MRSA) has become the bacteria of this decade.

Streptococcus aureus is a universally known gram-positive bacterium and is most commonly found in infections. It is also known to have an ability to evolve and adapt to antibiotics such as penicillin and methicillin. S. aureus was regularly treated with penicillin up until the point it obtained a resistance to penicillin around 1948. This occurrence caused the switch from penicillin to methicillin to treat infections with S. aureus. However, over time Streptococcus aureus gained and developed several strains that are resistant to methicillin around 1961. These strains are known as MRSAs, which is short for methicillin resistant Streptococcus aureus. (Robinson 2003) Although not everything about the methicillin resistance in S. aureus is known,